AdaptHealth (NASDAQ:AHCO) Posts Quarterly Earnings Results, Beats Expectations By $0.12 EPS

AdaptHealth (NASDAQ:AHCO) issued its earnings results on Tuesday. The company reported $0.37 EPS for the quarter, beating analysts’ consensus estimates of $0.25 by $0.12, Zacks reports. AdaptHealth had a negative net margin of 6.57% and a positive return on equity of 9.62%. AdaptHealth updated its FY 2025 guidance to EPS.

AdaptHealth Price Performance

Shares of AdaptHealth stock opened at $8.55 on Tuesday. AdaptHealth has a twelve month low of $7.25 and a twelve month high of $11.90. The firm has a market cap of $1.15 billion, a P/E ratio of -5.18, a price-to-earnings-growth ratio of 1.08 and a beta of 1.12. The firm’s 50-day simple moving average is $9.83 and its 200-day simple moving average is $10.19. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on AHCO. Truist Financial reduced their price target on AdaptHealth from $13.00 to $12.00 and set a “buy” rating for the company in a report on Friday, November 15th. Canaccord Genuity Group reduced their target price on shares of AdaptHealth from $14.00 to $13.00 and set a “buy” rating for the company in a research note on Wednesday, November 6th. UBS Group dropped their target price on AdaptHealth from $12.00 to $11.00 and set a “buy” rating on the stock in a report on Thursday, February 13th. Robert W. Baird dropped their target price on shares of AdaptHealth from $16.00 to $14.00 and set an “outperform” rating on the stock in a report on Wednesday, November 6th. Finally, Royal Bank of Canada decreased their price target on AdaptHealth from $13.00 to $11.00 and set an “outperform” rating for the company in a research report on Tuesday, November 19th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $12.20.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.